Biotech

All Articles

8 months after a $213M fundraise, gene publisher Volume makes decreases

.After raising $213 million in 2023-- among the year's most extensive personal biotech shots-- Volum...

BioMarin develops exec team with biotech vets-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of considerable management hirings, shootings a...

Biopharma Q2 VC struck highest level due to the fact that '22, while M&ampA decreased

.Equity capital backing in to biopharma rose to $9.2 billion across 215 sell the 2nd fourth of this ...

Bicara, Zenas seek IPOs to drive late-phase resources toward market

.Bicara Rehabs as well as Zenas Biopharma have actually given new catalyst to the IPO market along w...

Genentech to close cancer immunology analysis department

.Genentech will shut its cancer immunology study department, and device head and also well-known tis...

Kezar falls solid growth yet to show its truly worth in phase 1 test

.Kezar Life Sciences is actually dropping its own dim period 1 strong cyst medication as the biotech...

Acelyrin loses izokibep, lays off 3rd of team

.Regardless of izokibep sustaining its newly found winning touch in the medical clinic, Acelyrin is ...

Rivus' period 2 obesity-related cardiac arrest trial strikes endpoint

.Rivus Pharmaceuticals has plumped up the customers of its own fat-busting, muscle-sparing medicine ...

Ovid halts preclinical work, IV system after soticlestat fail

.Ovid Therapy already disclosed last month that it was actually trimming its headcount as the busine...

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Port

.Eli Lilly has actually opened up a $700 million R&ampD center in the Boston ma Seaport, improving i...